PCSK6 and neoplasm: The ML-peptide inhibits PACE4 with Ki value of 22 nM and exhibits potent anti-proliferative effect on PCa cell lines (DU145, LNCaP)12, however it only works in vivo if injected directly at the tumor site, whereas its intravenous administration is poorly effective13.